These cell lines do not possess MGMT over-expression or MMR deficiency that comprise major GBM resistance mechanisms to TMZ, represented in this work by human GBM U373-M and colorectal cancer HCT116 cell lines, respectively. This evidence concerns the gene MGMT and glioblastoma.